Ignite Creation Date:
2024-05-06 @ 4:22 PM
Last Modification Date:
2024-10-26 @ 2:09 PM
Study NCT ID:
NCT04968002
Status:
UNKNOWN
Last Update Posted:
2021-07-20
First Post:
2021-06-24
Brief Title:
Application of Pablizumab Combined With Apatinib and Chemotherapy in Resectable Non-small Cell Lung Cancer A Prospective Single Arm Single Center Phase II Clinical Study of Neoadjuvant Therapy
Sponsor:
Second Affiliated Hospital School of Medicine Zhejiang University
Organization:
Second Affiliated Hospital School of Medicine Zhejiang University
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-08-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2022-08-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-10-01
Completion Date Type:
ESTIMATED
First Submit Date:
2021-06-24
First Submit QC Date:
July 18 2021
Study First Post Date:
2021-07-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-07-18
Last Update Post Date:
2021-07-20
Last Update Post Date Type:
ACTUAL